Cardiac Guidance

The Caption Health, Inc. Cardiac Guidance device is an AI-powered system designed to assist medical professionals in acquiring high-quality cardiac ultrasound images for adult patients during 2D transthoracic echocardiography. It achieves this by providing real-time guidance, including a Quality Meter and Auto-Capture features, to standardize image acquisition and emulate the expertise of skilled sonographers.

A regulatory determination has been made regarding Caption Health, Inc.'s Cardiac Guidance device. This device, identified as a Class II radiological acquisition and/or optimization guidance system, was found to be substantially equivalent to previously marketed devices. This determination allows Caption Health, Inc. to market the Cardiac Guidance software, which is designed to assist medical professionals in acquiring cardiac ultrasound images. It functions as an accessory to compatible general-purpose diagnostic ultrasound systems, specifically indicated for use in two-dimensional transthoracic echocardiography (2D-TTE) for adult patients to acquire various standard cardiac views. Marketing of the device is subject to general controls and other applicable requirements. The review also included the clearance of a Predetermined Change Control Plan (PCCP), which outlines a framework for future software modifications that do not necessitate a new regulatory submission, provided they are consistent with the plan and do not significantly alter the device's safety, effectiveness, or intended use. The Cardiac Guidance software is an AI-powered system providing real-time guidance during echocardiography, featuring tools like a Quality Meter, Prescriptive Guidance, Auto-Capture, and Save Best Clip to emulate skilled sonographers. The updated PCCP expands upon prior authorizations by detailing anticipated algorithm improvements, support for additional cardiac views, and enhanced user interface compatibility, all subject to specific verification and validation testing to ensure continued safety and efficacy.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the AI's "emulation of skilled sonographers" translate into quantifiable improvements in image quality or diagnostic accuracy compared to traditional methods?; What specific validation and verification testing procedures are applied to ensure the continued safety and efficacy of algorithm improvements outlined in the PCCP?; Are there any contraindications or specific patient populations for which the Cardiac Guidance device's performance might be suboptimal or not recommended?; What is the learning curve for clinicians using this AI-powered guidance system, and what training is required to optimize its use in a clinical setting?; How does the device's performance, particularly its "Quality Meter" and "Auto-Capture" features, compare across different general-purpose diagnostic ultrasound systems it is compatible with?